The Chappel Group Research

The Chappel Group Research is a private U.S. clinical research company and investigative site organization based in Kissimmee, Florida. The company appears to operate as an independent clinical trial site supporting sponsor-led drug studies rather than as a drug developer with its own proprietary pipeline. Publicly visible evidence links the site to participation in multiple interventional studies across gastroenterology, cardiovascular disease, pain, and dermatology, including Phase 2 and Phase 3 trials sponsored by external biopharma companies. Available business-directory data suggest it is a small organization with a limited employee base and modest revenue. Overall, it looks most like a community-based healthcare clinical research site focused on patient recruitment and trial execution.